Lindsay Androski insider trades

Open-market stock purchases and sales by Lindsay Androski, President and CEO at Arbutus Biopharma Corp, from SEC Form 4 filings since Jul 1, 2022.

Recent trades

DateStockTradeValue
Oct 1, 2026ABUS Arbutus Biopharma CorpSold (not open market)$123K
Sep 18, 2026ABUS Arbutus Biopharma CorpSold (not open market)$418K
Sep 18, 2026ABUS Arbutus Biopharma CorpBought (not open market)—
Sep 18, 2026ABUS Arbutus Biopharma CorpBought (not open market)—
Feb 2, 2026ABUS Arbutus Biopharma CorpBought (not open market)—
Feb 2, 2026ABUS Arbutus Biopharma CorpBought (not open market)—

Companies traded

  • ABUS Arbutus Biopharma Corp: other filings, last Oct 1, 2026
  • ELOX Eloxx Pharmaceuticals, Inc: other filings, last Jan 24, 2025

Get free alerts when Lindsay Androski files a new trade →